LifeMD (LFMD) Stock Statistics & Valuation Metrics

LifeMD has a market cap or net worth of $473.11M. The enterprise value is $487.90M.

LifeMD has 45,447,605 shares outstanding. The number of shares has decreased by -2.65% in one year.

LifeMD’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is >-0.01%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, LifeMD had revenue of 212.45M and earned -18.88M in profits. Earnings per share was -0.53.

In the last 12 months, operating cash flow was 15.38M and capital expenditures -12.21M, giving a free cash flow of 3.17M billion.

LifeMD pays an annual dividend of ―, resulting in a dividend yield of ―

LifeMD upcoming earnings date is Aug 5, 2025, Before Open (Confirmed).

LifeMD as a current ratio of 0.81, with Debt / Equity ratio of -1077.79%

In the past 12 months, LifeMD has paid 402.00K in taxes.

LifeMD EV to EBITDA ratio is -29.16, with an EV/FCF ratio of 32.46.

LifeMD has $34.39M in cash and marketable securities with $25.10M in debt, giving a net cash position of -$9.29M billion.

Gross margin is 91.97%, with operating margin of -7.60%, and net profit margin of -8.89%.

The average price target for LifeMD is $14.60, which is 11.43% higher than the current price. The consensus rating is Strong Buy